Tetracycline-resistant bacteria were first isolated in 1953 from Shigella dysenteriae, a bacterium which causes bacterial dysentery. Since then tetracycline-resistant bacteria have been found in increasing numbers of species and genera. This has resulted in reduced effectiveness of tetracycline therapy over time. Tetracycline resistance is normally due to the acquisition of new genes often associated with either a mobile plasmid or a transposon. These tetracycline resistance determin~mts are distinguishable both genetically and biochemically. Resistance is primarily due to either energy-dependent efflux Of tetracycline or protection of the ribosomes from the action of tetracycline. Gram-negative tetracycline efflux proteins are linked to repressor proteins which in the absence of tetracycline block transcription of the repressor and structural effiux genes. In contrast, expression of the Gram-positive tetracycline efflux genes and some of the ribosomal protection genes appears to be regulated by attenuation of mRNA transcription. Specific tetracycline resistance genes have been identified in 32 Gram-negative and 22 Gram-positive genera, Tetracycline-resistant bacteria are found in pathogens, opportunistic and normal flora species. Tetracycline-resistant bacteria can be isolated from man, animals, food, and the environment. The nonpathogens in each of these ecosystems may play an important role as reservoirs for the antibiotic resistance genes. It is clear that if we are to reverse the trend toward increasingly antibiotic-resistant pathogenic bacteria we will need to change how antibiotics are used in both human and animal health and food production.
Introduction
Tetracyclines are broad-spectrum antimicrobial agents with activity against a wide range of Grampositive and Gram-negative anaerobic and aerobic bacteria, cell-wall free mycoplasmas, chlamydiae, mycobacterium, rickettsia, Helicobacter, Listeria and protozoan parasites such as Entamoeba histolytica, Giardia lamblia, and Plasmodium falciparum [1] [2] [3] [4] [5] [6] . They have been used extensively for therapy in man for bacterial respiratory and urogenital tract diseases, periodontal, Lyme, and rickettsial diseases. Tetracyclines were the first major group of antibiotics to which the term 'broad-spectrum' was used. Chlortetracycline was discovered in 1947, followed closely by oxytetracycline and tetracycline. Doxycycline was introduced in 1966 and minocycline in 1972 [1] . Because of the spectrum of activity, the relative safety and low cost, tetracyclines have been widely used throughout the world and are second after penicillins in total tons used each year [7] . In the last ten years, the therapeutic use of tetracyclines in human medicine has been reduced as bacterial resistance has become more widespread [l, 2, 6] .
Oxytetracycline has been used to treat certain bacterial diseases which effect field crops and fruit trees and in subtherapeutic levels as food additives for growth promotion in billions of animals raised for food each year. Use of oxytetracycline in food production ranges from chickens, cows, honeybees, salmon, and catfish [1] . The food industry is an important user of antibiotics and in many industrialized countries the total amount of antibiotic used for food production exceeds the amount used in human medicine and thus a significant factor in exposing bacteria to antibiotics [1] . Tetracyclines are also used for therapy in food animals and in pets such as dogs, cats, and horses [1] . The bacteria which cause disease in animals and plants can be of the same species as those found in man, may belong to related species found within the same or related genera as those found in man, or more distantly related. Unique plasmids and antibiotic resistance genes first described in animal specific bacteria have made their way into human bacteria and vice versa [1, 6] . Similarly, bacterial plant pathogens have had their antibiotic resistance genes show up in related genera which inhabit man [1] . The reason this happens is due to the fact that bacteria exchange antibiotic resistance genes. Thus, a bacterium unique to a food animal or fruit tree disease which acquires tetracycline resistance as a result of treatment with oxytetracycline may pass that gene to other species and genera and ultimately influence the antibiotic resistance carriage of strictly human bacterial species [1, 6] . The result is that antibiotic use anywhere in the world, regardless of its original purpose, can effect the antibiotic resistance genes in bacteria in other ecosystems including those that are pathogenic for man. Thus, the total use of antibiotics not just those used to treat man play a role in the dramatic increase in the number of species throughout the world which now carry antibiotic resistance genes. Another related concern is the potential that antibiotic residue may be left on or in food which once ingested can directly influence selection of antibiotic-resistant bacteria found in man.
Tetracyclines gain access into the bacterial cell by passive diffusion through hydrophilic pores in the outer cell membrane and then through the inner cytoplasmic membrane by an energy-dependent active transport [2, 8] . Tetracyclines are actively concentrated by most bacterial cells while they are not concentrated by mammalian cells. This difference explains tetracyclines selective action against bacteria [2, 9] . 'Typical tetracyclines', which include tetracycline, chlortetracycline, minocycline and doxycycline, prevent growth of the bacteria by reversibly binding to the ribosomes and inhibiting protein synthesis; they are bacteriostatic agents which inhibit rather than kill in vitro [2] . These tetracyclines bind to the bacterial 30S ribosomal subunit and prevent attachment of aminoacyl-tRNA to the ribosomal receptor site in a reversible fashion. The precise mechanism is not well understood but it is possible that when the tetracycline binds to the ribosome there is a change in the chemical reactivity within the ribosome so that it no longer functions properly, or binding of the tetracycline may cause distortion of the three dimensional structure of the ribosome which then could lead to changes in the accessibility of bases within the 16S rRNA [2] . Another possibility is that binding of the tetracycline may block the entry of the aminoacyl-tRNAs into the ribosome [10] . The important proteins in the 30S subunit for high-affinity binding of tetracycline include $3, $7, S14 and S19 with evidence that tetracycline binds directly to $7 [11] . The 16S rRNA in the region of nucleotide 892 through nucleotide 1054 may be involved in the antibiotic binding of tetracycline and nucleotide 1052-1054 has been suggested as the most likely to be associated with inhibition of protein synthesis [2] . A second group of tetracycline analogs which include: chelocardin, anhydrotetracycline, 6-thiatetracycline and anhydrochlortetracycline labeled 'atypical tetracyclines' have also been examined [9, 12] . These antibiotics appear to be bactericidal and interfere with membrane permeability resulting in cell damage which leads to cell lysis and death in vitro [9, 12] . There is no direct association between these atypical tetracyclines and the inhibition of protein synthesis by binding to the ribosomes [12] . Chelocardin and 6-thiatetracycline both had toxic side effects perhaps associated with their ability to interact with mammalian membranes. More recently, the glycylcyclines which are N,N-dimethylglycylamido derivatives of minocycline and 6-dimethyl-6-deoxytetracycline have been examined [13] . These compounds appear to be less toxic than many of the atypical tetracyclines, are generally not affected by either efflux or ribosomal protection tet genes and hold some promise for the future [13] .
Tetracyclines also have non-antibacterial properties which include antiinflammatory and immunosuppressive properties [14] . Studies have linked tetracycline with suppression of antibody production in lymphocytes, reduction in phagocytic function of polymorphonuclear leukocytes, reduction of leukocyte and neutrophil chemotaxis, as a sclerosising agent, as an inhibitor of lipase and collagenase activity and as an enhancer of gingival fibroblast cell attachment [14, 15] . Recently, a new tetracycline from a Streptomyces sp. has been shown to have antitumor activity against murine leukemia in vivo [16] . These additional properties have encouraged the use of tetracycline in non-infectious conditions such as resistant rheumatoid arthritis, rosacea, pyoderma gangrenosum, prurigo pigmentosa, pleural effusions, recurrent pneumothorax, recurrent thyroid cysts, and biliary-cutaneous fistula. These uses unfortunately expose the patient's normal flora to active tetracycline which can select for tetracycline-resistant bacteria as does tetracycline used for treatment of an infectious disease. It would be a significant advance if analogs of tetracycline, which maintain these other useful properties but no longer had antibacterial properties, could be made for use in these noninfectious diseases.
In 1953, the first tetracycline-resistant bacterium isolated was S. dysenteriae, which causes bacterial dysentery [17] . The first multi-resistant Shigella was isolated in 1955 and was resistant to tetracycline, streptomycin, and chloramphenicol [17] [18] [19] and came from a total of 5327 (0.02%) isolates tested. By 1960, multi-resistant Shigella represented almost 10% of the strains tested in Japan [17] [18] [19] , a dramatic increase in five years. The increase in multi-drug resistant ShigeUa has continued to the present as illustrated by a recent study [20] where over 60% of the S. flexneri isolated between 1988-1993 were resistant to tetracycline, streptomycin, and chloramphenicol. This is the same combination of antibiOtic resistance determinants found in the 1953 S. dysenteriae isolate: Subsequently, it was demonstrated that these antibiotic-resistant bacteria could transfer their antibiotic-resistant phenotypes to susceptible isolates by cocultivation. This transfer was dependent upon direct contact of the bacteria, [19] . We now know that the Japanese studies were the first reports of tetracycline resistance genes carried on conjugative R-plasmids. These tetracycline genes coded for the efflux of tetracycline out of the cell and were the first of the three different tetracycline resistance mechanisms found in bacteria [6] .
Multi-drug resistance, which includes tetracycline resistance, has also been seen in Gram-positive species. A recent 1994 study [13] indicated that approximately 90% of methicillin-resistant Staphylococcus aureus, 70% of Streptococcus agalactiae, 70% of multi-drug resistant Enterococcus faeca!is and: 60% of multi-drug resistant S. pneumoniae now are tetracycline-resistant. This suggests that tetracycline resistance has become widespread in pathogenic Gram-positive species as well as among pathogenic Gram-negative species and is often found in multi-drug resistant bacteria. It has been found that extended use of tetracycline may select for both tetracycline and multi-drug resistant bacteria [1] . This situation applies equally .to animals given low dose tetracycline for growth promotion and patients given long term tetracycline for control of acne [1] .
Since 1960, investigators have found that bacterial resistance to tetracyclines is primarily due to acquisition of tetracycline resistance determinants rather than by mutation of existing chromosomal genes [6, 21] . However, some exceptions have been described. For example, in Neisseria gonorrhoeae the additive effects of mutations to chromosomal genes tet, mtr and penB can result in clinical failure of tetracycline therapy [6] . A chromosomal tetracycline effiux system assqciated with the mar locus in E. coli ha~ also been described [8] . The mutation in the marA region of the chromosome enhances intrinsic resistance to a large group of antibiotics. The ,level of tetracycline resistance increased as the cells were grown continually in the presence of tetracycline. The mar locus appears to be widely established in enteric bacteria. High-level Mar mutants show decreased accumulation of tetracycline and an energy-dependent tetracycline efflux system [8] . The efflux is dependent on the expression of the mutant marA region and inactivation of the region creates a susceptible phenotype [8] . Mutation of the nalB gene on the chromosome of Pseudomonas aeruginosa increases resistance to multiple antibiotics. A multi-drug resistance operon mexA-mexBoprM has been identified in P. aeruginosa [22] which confers resistance to tetracycline, ciprofloxacin and chloramphenicol. Proteins from this operon show homology with export-effiux proteins. Spontaneous multi-drug resistant mutants of Klebsiella pneumoniae, which have increased resistance to a range of unrelated antibiotics including tetracycline, have also been described [23] . Similar mutants have been found in Serratia marcescens, Enterobacter spp. and Campylobacter [24] . These multi-drug resistant mutants exhibited an effiux of tetracycline which is similar to the E. coli Mar mutants. However, as stated above, high-level tetracycline resistance in Gram-negative species is still primarily associated with the acquisition of new genes in clinically relevant isolates rather than by mutation of existing chromosomal genes (Table 1) [21 ].
Mendez et al. [25] first examined the genetic heterogeneity of tetracycline resistance determinants from Enterobacteriaceae and Pseudomonadaceae plasmids using restriction enzyme analysis, DNA-DNA hybridization and expression of resistance to tetracycline and various analogs. DNA-DNA hybridization with the structural genes as probes, is a standard method used to distinguish different genes [26] . A new gene is identified by its inability to hybridize with any of the known tet genes under stringent conditions which indicates < 80% sequence identity using this criterion. If this is demonstrated then a letter designation is given in accordance with nomenclature standards [26] . Many of the different tet genes share significant homology as illustrated by tetM, tetO and tetS, which share 75% sequence identity with each other however, under stringent hybridization conditions, they do not cross-hybridize and are thus considered separate genes. There have been 16 different tetracycline- [28] . One has been cloned from P. aeruginosa [29] , and we have shown that it does not hybridize with either Tet G or Tet H determinants and thus could be given a designation of Tet I since it meets the current criteria for a new determinant (author's unpublished observation). This is shown in Table 1 as Tet I. The other new determinant has not been as well studied and has not been included in Table 1 . In addition, three oxytetracycline (Otr) determinants, first described in the antibiotic producing Streptomyces [30] [31] [32] [33] are included in the review.
Fifteen of the tet genes and two of the otr genes are known to code for one of two mechanisms of tetracycline resistance, either efflux or ribosomal protection. The tetI gene most likely codes for an efflux system, while the third otr gene's mechanism of resistance is not known. The tetX codes for an enzyme which inactivates tetracycline. This enzyme is a novelty because it is the first and only enzyme described which inactivates tetracycline. However, it does not seem to have much clinical relevance since it requires oxygen to function and is found only in strict anaerobes where oxygen is excluded [21] . Thus, it is unlikely that the tetX gene functions in its natural hosts.
Mechanisms of resistance

Nomenclature for tetracycline resistance determinants
In 1989, Levy and colleagues proposed DNA-DNA hybridization as the standard for grouping related genes coding for tetracycline resistance together [26] . Since then only a limited number of genes have been sequenced, with the exception of those belonging to the M class. The result of this is that DNA-DNA hybridization is still used as a standard for determining different classes of tetracycline resistance genes rather than DNA sequencing of individual structural genes. Each class is desig-nated by a different capital letter [26] . When referring to a particular determinant it was recommend that the designation of Tet A, Tet B etc. be used with a space between the Tet and capital letter [26] . The structural genes of any class would be designated as tetA(P) for the first gene and tetB(P) for the second gene as is found in the class P [34] . However, all other classes of tetracycline resistance genes, that have been described, carry a single structural gene. Thus, the structural gene from the Tet A determinant can be called either tetA(A), tet(A) or tetA without confusion [26] . Both tet(A) and the tetA designation are equally accepted for the gene name and the latter is used in this review. The protein product of the tetA gene is designated as either TetA(A) or TetA.
The latter is used in this review. When only a single gene or protein is discussed or when the term is used generically then it is acceptable to refer to the gene as tet and the protein as Tet [26] .
Repressor genes which are found in the Gramnegative effiux classes are designated as tetR(A) for the repressor gene associated with the class A, tetR(B) for class B etc. The protein produced from tetR(A) is designated TetR(A) or TetR [26] . In many papers only a single class is being described thus a shortened form of the gene (tetR) and protein (TetR) has been used.
The oxytetracycline resistance use otr rather than tet for gene names and Otr instead of Tet for protein names, but otherwise are named as described above [31] [32] [33] .
Efflux proteins
Efflux proteins have been the best studied of the Tet determinants and tetA, tetB, tetC, tetD, tetE, tetG, tetH, tetK, tetL, tetA(P) and otrB genes have been identified. However, it is likely that the tetl gene also codes for an effiux protein. The presence of both tet and otr genes with the same mechanism of resistance is consistent with the hypothesis of lateral gene transfer from the tetracycline-producing streptomycetes to other bacteria [35] . All of these genes code for energy-dependent membrane-associated proteins which export tetracycline out of the cell. The export of tetracycline reduces the intercellular concentration of tetracycline and thus protects the ribosomes in vivo but not in vitro. Efflux genes are found in both Gram-positive and Gram-negative species (Tables 1 and 2 ). The Gram-positive genes tetK, tetL and tetA(P) and the Gram-negative genes tetA, tetC, tetD, tetE, tetG, tetH code for efflux proteins which confer resistance to tetracycline but not minocycline. In contrast, the Gram-negative tetB gene codes for an efflux protein which confers resistance to both tetracycline and minocycline [2, 25] . Recently, Guay et al. [36] suggested that the TetB protein's ability to confer minocycline resistance was not due to the TetB protein substrate specificity for minocycline, but rather TetB was a better pump when compared with other Tet efflux pumps. None of the efflux genes examined confer resistance to the new glycylcycline compounds [13, 36, 37] . In the laboratory, Guay could make specific mutations in the TetB protein which increased the cells resistance to glycylcyclines but also reduced resistance to tetracycline. More needs to be done in comparing the resistance of minocycline among the various efflux proteins.
Each of the efflux genes codes for an approximately 46 kDa membrane-bound efflux protein which has 12 (Gram-negative) or 14 (Gram-positive) hydrophobic membrane-spanning regions (c~ helices span the inner membrane) separated by a short central hydrophilic region of amino acids [2] . Most of the protein appears to reside in the lipid bilayer with the hydrophilic amino acid loops protruding into the periplasmic and the cytoplasmic space. Genetic studies suggest that the Tet protein exists as a multimer in the cell membrane. The efflux proteins exchange a proton for a tetracycline-cation complex against a concentration gradient [38] . The Gram-negative efflux genes have two functional domains, ~ and /3 which correspond to the N-and C-terminal halves of the protein respectively [39] . Mutations in either half of the protein eliminates resistance, suggesting that the residues dispersed across the protein are important for function. Proteins TetA and TetC form one genetic group which shares approximately 78% of the amino acid sequences in common with each other. The TetG protein is also part of this genetic group [40] . A second genetic group includes proteins TetB, TetD, TetE and TetH [40] . Experiments to make c~-/3 hybrid proteins using two Tet determinants have shown that proteins created which carry a domain from the same genetic group (TetA and TetC Reciews 19 (1996) or TetB and TetD) make a protein which restored partial tetracycline resistance, but if two determinants from opposite genetic groups (TetA and TetB, or TetC and TetD) were combined the hybrid protein did not restore activity [39] . More recently, genetic analyses using mutations in specific codons have been done [41 ] .
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Tetracycline efflux proteins share amino acid and protein structure similarities with other efflux proteins involved in multiple-drug resistance, quaternary ammonium resistance, chloramphenicoi and quinolone resistance and include methylenomycin A (MetA) from Streptomyces coelicolor, aminotriazole transport (Atrl) from Saccharomyces, and arabinose transport (Arab) from Escherichia coli [8, 42] . Homology between the Tet and other efflux proteins has also been found with a new protein (EfaA) recently cloned from Mycobacterium tuberculosis (author's unpublished observation, manuscript in preparation), pH-dependent mutations in the efflux proteins have been located in loop A and loop B [2] . McNicholas et al. [41] have hypothesized that the periplasmic region connecting transmembrane helices 9 and 10 and cytoplasmic loops A and B within the efflux protein interact functionally as the proton pump in the Gram-negative proteins.
The Gram-negative efflux genes are widely distributed and normally associated with large plasmids, most of which are conjugative. They come from a number of different incompatibility groups [25, 28] . These plasmids often carry other antibiotic resistance genes and thus selection for tetracycline resistance may select for multi-resistant isolates or selection for another antibiotic which the plasmid carries can select for tetracycline resistance. This phenomenon has contributed to the dramatic increase in multi-drug resistant bacteria over the last 40 years [1, 6] . The tetK and tetL genes share 60-63% DNA sequence identity with each other. These genes code for proteins which confer resistance to tetracycline and chlortetracycline and their presence is indicated when Gram-positive bacteria are resistant to tetracycline but not to minocycline. Tet K and Tet L determinants are generally found on small transmissible plasmids which on occasions become integrated into the chromosome of staphylococci [43] the chromosome of Bacillus subtilis [44] or on larger staphylococci plasmids ( [45] , author's data, manuscript in preparation). The large staphylococcal plasmids carrying the Tet K determinant are relatively uncommon, while the small plasmids carrying the Tet K determinant are common. The small plasmids represent a family of closely related plasmids which range in size from 4.35 to 4.7 kb [46] . pTl81 is the prototype of the family and has been completely sequenced [47] . This plasmid has three genes, the structural tetK, the repC gene which codes for a protein involved in plasmid replication and a third gene which codes for a recombinase [47, 48] . The pT181 family of plasmids can carry antibiotic resistance genes other then tetK [46] . The large plasmid pJ3358 from Staphylococcus aureus, which codes for mupirocin resistance also carries a complete copy of plasmid pT181 flanked by directly repeating insertion sequences IS257 [45] . A chromosomally integrated copy of plasmid pT181 is also flanked by IS257 elements [49, 50] . More recently, we have examined four large staphylococcal plasmids from four species. In each case, a copy of pT181 was within the large plasmid and flanked by IS257 sequences (author's data, manuscript in preparation). In one plasmid, part of the pT181 sequences has been deleted, while in the other plasmids the complete pT181 plasmid sequence appears to be present as judged by Southern blot hybridizations (author's data, manuscript in preparation).
A small number of tetL genes have been sequenced and shown to share between 98-99% DNA sequence identity with each other [51] . One exception is the integrated tetL gene cloned from the chromosome of B. subtilis [44] . This gene shared only 81% DNA sequence identity with the other sequenced tetL genes and is just at the limit of what would be considered as part of the class L group. The tetK and tetL genes can be found together in single isolates such as staphylococci (author's unpublished data) and C. difficile [52] , but can not be distinguished by their resistance to different tetracyclines. To help determine which efflux genes the various species carry, we have developed a single PCR assay which will detect both tetK and tetL genes [53] . This has made it easy to examine the distribution of these two genes from a large number of isolates.
Ribosomal protection proteins
Proteins that protect the ribosomes from the action of tetracycline both in vivo and in vitro confer resistance to tetracycline, doxycycline and minocycline. Tet M, Tet O, Tet S, Tet B(P), Tet Q, and Otr A determinants code for approximately 72.5 kDa cytoplasmic proteins which are similar in their Nterminal amino acid sequences to the elongation factors Tu and G [10, 54] . The GTP-binding domain in the N-terminal region has five highly conserved motifs. Taylor and Chau [10] recently reviewed what is known about the structural similarities between the ribosomal protection proteins and the various elongation factors. Within the G domain is a 90 amino acid region termed the G' subdomain. The ribosomal protection proteins contain significant portions of the G' subdomain but are also missing other parts. Similarities are also found in regions II, III, IV and V between ribosomal protect proteins and EF-Tu and EF-G [10] .
We have compared the DNA sequence of the structural tetM gene (accession number U08812) of the Ureaplasma urealyticum, a cell-wall free bacteria, with that of Tn916 (accession number U09422), Tn1545 (accession number X04388), S. aureus (accession number M21136), N. gonorrhoeae (accession numbers L12241, L12242), N. meningitidis (accession number X75073) and have found between 95-99% identity. The structural genes of tetO, tetS and tetQ share 76%, 78% and 56% identity, respectively, with the U. urealyticum tetM (author's unpublished observations). Because of the relationship between tetM, tetO, and tetS, we have been able to develop a single PCR assay which screens for all three of these determinants [55] . The OtrA and the TetB(P) proteins form a second sequence group and the TetQ protein, a third group [34] . The Tet determinant from Clostridium is unusual because it consists of two overlapping genes tetA(P) which encodes a classical efflux protein and a second gene tetB(P) which codes for a protein which looks related to the tetracycline ribosomal protection proteins. No other gene with this organization has yet been described. It has been shown that the tetA(P) is functional but it is not clear whether the tetB(P) codes for a functional protein since in both Clostridium perfringens and E. coli carrying the cloned tetB(P) only a low-level resistance is expressed [34] . Thus, like the tetX gene described below, the tetB(P) gene may not be functional in its natural host.
The similarities in amino acid sequences between the ribosomal protection proteins and the elongation factors Tu and G suggested that the ribosomal pro-teins might function as tetracycline-resistant elongation factors, or by blocking the binding of tetracycline to the ribosome [54] . H3-tetracycline appears to bind equally well to both ribosomes with the TetO protein (tetracycline-resistant) and tetracyclinesusceptible ribosomes over a range of concentrations [10] which seems to suggest that simply blocking the binding of tetracycline is not the most likely mechanism of action for these proteins. Burdett has shown ribosome dependent GTPase activity in the TetM protein while similar activity has been more recently found in the TetO protein [10] . If the TetM or TetO proteins are removed from the ribosomes then the ribosomes become tetracycline-susceptible. This makes a transient unstable modification of the sort suggested by Manavathu et al. [57] , unlikely. More recently, Burdett [58] has isolated an E. coli miaA mutant which has pleiotrophic effects one of which is that when the Tet M determinant is present in the cell it does not confer resistance to tetracycline. One of the results of this mutation is the lack of modification of an adenosine at position 37 in the tRNA which reduces the affinity of the tRNA to the ribosome. This may explain the reduction of tetracycline resistance in E. coli miaA mutants carrying the Tet M determinant. The Streptomyces otrA gene codes for a protein with this same ribosomal protection mechanism of resistance and has more overall amino acid similarity with elongation factors than either the TetM or TetO proteins [31] . Even with all the work on these proteins the exact mechanism of resistance is still not clear.
An interesting property of ribosomal protection proteins is that they do not normally confer high-level tetracycline resistance, as compared to the efflux genes, when cloned into E. coli [59] . Even when cloned into moderate level copy number plasmids the ribosomal protection proteins confer resistance at 10-25/zg/ml in E. coli. This is in contrast to efflux genes which confer resistance at 4-10-fold higher level of antibiotic in E. coli. Even though the Tet M determinant is not found in enteric Gram-negative bacteria, this group has the widest host range of any Tet determinant and is found in a number of Gramnegative genera (Tables 1 and 2) including Neisseria gonorrhoeae [60] , Haemophilus ducreyi [61] , Neisseria spp. [62] , Campylobacter spp. [63] , a variety of anaerobes [64] and more recently with Pasteurella spp. [65] . One possible explanation for this distribution and lack of ribosomal protection genes in the enterics is the relatively low level resistance conferred compared to resistance conferred by efflux proteins. Thus, the ribosomal protection mechanism of resistance might not provide much survival value in the presence of tetracycline in nature for the enteric bacteria. In contrast, these genes do provide good levels of tetracycline protection for bacteria like Neisseria spp. and Haemophilus [6, 57, [60] [61] [62] . However, more work is needed to better understand the absence of these proteins in the enteric group but presence in other Gram-negative species (Table 1) .
Enzymatic inactivation of tetracycline
The only example of tetracycline resistance due to the enzymatic alteration of tetracycline is coded by the Tet X determinant [66] . Two closely related anaerobic Bacteroides transposons containing the Tet X determinant have been described [66] . This gene was found because tetX is linked to ermF, which codes for a rRNA methylase gene. The ermF gene was cloned into E. coli and the clones were found to confer tetracycline resistance in E. coli when grown aerobically. The gene product was shown to be a 44-kDa cytoplasmic protein that chemically modifies tetracycline in the presence of both oxygen and NADPH. Sequence analysis indicates that this protein shares amino acid homology with other NADPH-requiring oxidoreductases and should not be able to function in the natural anaerobic Bacteroides host [66] . It has not been found outside Bacteroides. However, to date a survey has not been done to assess the distribution of this determinant. Thus, even though the transposon carrying tetX and linked ermF is thought to be of Grampositive aerobic/facultative origin, a putative ancestor has not been identified.
The mechanism of resistance of the Otr C determinant from Streptomyces has not been determined. It has been speculated that otrC gene does not code for either an efflux or ribosomal protection type protein. Whether otrC gene codes for an inactivation enzyme similar to TetX or whether it has a novel mechanism of resistance has not been determined at this time.
Regulation of Tet determinants
Efflux genes
The Tet A through Tet E, Tet G and Tet H determinants are unique with respect to genetic organization and regulation of expression [67] . [67] . The amino acid sequences of the efflux proteins share 43-78% identity and 114 (28%) of the amino acids residues are common to all seven Gram-negative tet genes [40] indicating divergence from a common ancestor. The repressor proteins also share significant homology (43-70%) with 29% of the residues identical in the six repressors, from TetR(A) through TetR(E) and TetR(G), examined [40] . Most of the work on regulation has been done with Tn 10 which codes for the TetA(B) efflux and TetR(B) repressor proteins.
In the absence of tetracycline, the repressor protein occurs as a homodimer which binds two c~-helix-turn-c~-helix motifs to the two tandemly orientated tet operators [67, 68] . This blocks transcription of both the repressor and structural efflux genes. Induction in the system occurs when a tetracyclineMg 2+ complex enters the cell and binds to the repressor protein. The binding causes a change in the conformation of the repressor and the induced repressor no longer binds to the DNA operator region. Only nanomolar concentrations of tetracycline are needed for the binding to occur. This system is the most sensitive effector-inducible transcriptional regulation system yet described. After the repressor binds the tetracycline-Mg 2+ complex, transcription of the efflux structural and repressor genes occurs. This is a relatively quick process [69] . The tet gene in TnlO is differentially regulated so that the repressor protein is synthesized before the efflux protein is expressed. The repressor protein will rebind to the DNA only when there is no longer enough tetracycline (< nanomolar amounts) present in the cell. This type of regulation most likely occurs with all the Gram-negative efflux determinants (Tet A, Tet C, Tet D, Tet E, Tet G, and Tet H) since they have a common genetic organization. This may also be true for the Tet I determinant. Recent work by Kisker et al. [68] using crystallography has shown that the N-terminal three ce-helices of the repressor protein form the DNA-binding domain in the repressor molecule. Conformational change in the repressor protein occurs in the presence of tetracycline complexed with Mg 2+. They have also characterized the tetracycline binding pocket and the interaction between tetracycline and the repressor protein in a detailed review [67] .
Three different strains of Haemophilus parainfluenzae have been shown to carry constitutively expressed Tn 10 [69] . Subsequently it was shown that a truncated nonfunctional repressor protein due to a frame-shift mutation in the repressor gene was present [70] . This resulted in the constitutive expression of the TetB protein. However, when a functional repressor was added to the cell the tetB gene was inducible and regulated normally. How common defective repressors are in nature outside the genus Haemophilus has not been examined.
No repressor proteins have been found in Grampositive Tet K or Tet L determinants. Instead the tetK and tetL efflux genes are thought to be regulated by attenuation of the mRNA [51] . Most of the evidence is based on DNA sequence data, but it appears that the mRNA contains two ribosomal binding sites (RBS). In the absence of tetracycline the ribosome binds to the first ribosomal binding site (RBS 1) and a short leader peptide is translated which ends before the second ribosomal binding site (RBS2) which precedes the start of the structural tet gene. In the presence of tetracycline, a second stem-loop structure in the mRNA is thought to form which uncovers the RBS2 site and allows the efflux protein to be translated, resulting in the cell becoming phenotypically resistant to tetracycline [51] . The regulation of tetK and tetL genes has not been studied extensively. However, it is reasonable to assume that changes in regulation from inducible to constitutive production of Tet K and Tet L proteins may be similar to what has been found for other Gram-positive genes regulated by attenuation such as the ermC where significant work has been done on the regulation (inducible vs. constitutive). Now clinical isolates with either inducible or constitutively regulated ermC genes can be isolated. In one isolate, a tandem 26 bp direct repeat was found in the leader sequence [71] , while in a second isolate a deletion of the 107 bp segment of the leader region was found [72] . In both cases these changes were thought to have converted an inducibly regulated leader region into a nonfunctional leader region which resulted in constitutive production of the ErmC protein.
Ribosomal protection
The expression of both Tet M and Tet O proteins appears to be regulated. Wang and Taylor [73] have suggested that the 400 bp region directly upstream from the coding region of tetO gene was needed for full expression of the gene, however the function of the region is not understood [10] . Burdett [56] reported that the amount of the TetM protein increased when streptococci carrying the determinant were exposed to tetracycline. Similarly, Nesin et al. [74] found preexposure to subinhibitory concentrations of tetracycline in a Staphylococcus aureus, carrying the Tet M determinant, showed an increase in its tetracycline minimum inhibitory concentration and had an increase in the level of mRNA transcripts for tetM. More recently Suet al. [75] reported a stemloop structure in the upstream region of the structural gene from Tn916 and both short and long transcripts were found by Northern blots similar to what has been described for attenuation of mRNA transcription of Gram-positive proteins. Based on the DNA sequences from the upstream region in the U. urealyticum terM sequence a similar stem-loop structure to that described for Tn916 would be possible (unpublished observations). However, we have not looked at the transcripts from this gene.
We have sequenced the 4.9 kb HinclI fragment containing the tetM gene from U. urealyticum while more recently the complete Tn916 has been sequenced [76] . We have compared the upstream regions of seven tetM genes using the U. urealyticum as the standard. Between 100 and 500 base pairs were available for these comparisons including Tn916, Tn1545, and tetM genes from a diverse group of isolates including S. aureus, N. gonorrhoeae, N. meningitidis with U. urealyticum. We found that the seven upstream regions examined shared between 96-100% sequence identity with the U. urealyticum upstream sequences (authors unpublished observations). In contrast, when downstream regions were compared, sequence identity was more variable and ranged from 81-99%. The S. aureus sequences [74] were the most diverse with only 81% sequence identity. Finding little variability in the upstream sequences and more variability in the downstream regions is consistent with the hypothesis that the upstream regions are important for regulation, while no role has been described for sequences directly downstream of the structural gene. The sequences of both the upstream and downstream regions, as well as, the structural genes have G + C contents of < 40%. This is despite the fact the genes were isolated from bacteria which have chromosomal G + C contents that varied from a low of 28% (U. urealyticum) to a high of 50% (Neisseria spp.). Finding that not only the structural genes but regions upstream and downstream of the structural genes have a < 40% G + C in all the Tet M determinants is consistent with the hypothesis that the tetM genes have come from Gram-positive bacteria and illustrates the spread of Gram-positive genes into Gramnegative species [6] .
DNA sequences upstream from the structural genes of tetO, tetS and tetQ shared 71%, 76% and 59% sequence identity, respectively, with the U. urealyticum upstream sequences. This information along with the information from Wang and Taylor [73] is consistent with the hypothesis that these genes may also be regulated. However, the regulation of tetQ expression is unclear since most of the work has been done to determine regulation of self-transfer and for mobilization of both coresident plasmids and unlinked integrated elements rather than expression of the TetQ protein [77, 78] . There is also no direct data for regulation in tetS. There have not been adequate downstream sequences (< 100 bp) available in GenBank and thus we could not compare downstream regions of tetO, tetS and tetQ with the tetM downstream sequences.
Distribution and mobility of the Tet determinants
Tet determinants are found in a variety of bacteria isolated from man, animals and the environment (Table 1 ). The majority of the Tet determinants are associated with either conjugative or mobilizable elements which may partially explain their wide distribution among bacterial species [25, 28] . The Gram-negative Tet efflux determinants are found on transposons inserted into a diverse group of plasmids from a variety of incompatibility groups [25, 28] . Gram-positive efflux genes are normally associated with small mobilizable plasmids [47, 51] . The ribosomal protection genes tetS and tetO can be found on conjugative plasmids, or in the chromosome where they are not self-mobile [27, 63] . The tetM and tetQ determinants are generally associated with conjugative chromosomal elements, which code for their own transfer [77] [78] [79] [80] [81] [82] [83] . These conjugative transposons have been shown to transfer mobilizable plasmids to other isolates and species and even unlinked genomic DNA [77] [78] [79] [80] [81] . Genes in the tetQ operon have been identified which mediate excision and circularization of discrete nonadjacent segments of chromosomal DNA in Bacteroides. The transfer origin (oriT) region of one of the Bacteroides conjugative transposons has been located near the middle of the conjugative transposon [77] . Bacteroides conjugative transposons can range from 65 to over 150 kb, most elements carry both tetQ and ermF and belong to a family of elements with the prototype being Tc r Em r DOT [78] . A 16 kb region of the transposon is required and sufficient for conjugal transfer of the element, and for mobilization of both coresident plasmids and unlinked integrated elements. DNA transfer is tetracycline-regulated and mediated by at least three regulatory genes including a putative sensor (rteA), a putative regulator (rteB), and a third gene rteC which seems to stimulate transfer in an unknown fashion [77] . This differs from the mechanism proposed for tetracycline regulation of conjugation of the Tn916 family of elements where Manganelli [82] suggests that tetracycline increases the number of circular intermediates present in the cell which leads to more transconjugants. Movement of the Tn916-1ike and Bacteroides conjugative elements are hypothesized to involve a Rec-independent excision event which produces a nonreplicative circular intermediate that can insert at a different site within the cell or transfer to a new host by a conjugative plasmid-like process [79, 83] . The Bacteroides conjugative transposons integration into a new host is relatively site specific [78] , while the Tn916-1ike transposons can be relatively site specific or more randomly integrated into the host chromosome depending on the host [83, 84] , integrated into plasmids [85] , or integrated within conjugative transposons to create composite elements [79] . These composite Gram-positive elements are > 50 kb and have been found in streptococci and enterococci. The prototype of the composite element is Tn3703 first described in S. pyogenes [86] . In some of these composite elements, the central Tn916-1ike element can be removed and the nonhomologous segment can undergo conjugative transposition independently as occurs in Tn5253 from S. pneumoniae [79] . Structural organization of these composite elements vary. Both the composite and the Tn916 family of elements can carry antibiotic resistance genes which confer resistance to chloramphenicol, erythromycin and kanamycin in addition to the tetM gene which confers resistance to both tetracycline and minocycline [79, 86] .
The Bacteroides conjugative transposons can mobilize resident plasmids either in trans or in cis. In trans the transposon provides all the proteins needed for mating and the plasmid provides the proteins that nick the plasmid and initiate plasmid transfer. In cis, the transposon provides the proteins needed for transfer [78] . The Tn916 family can mobilize plasmids in trans [79] [80] [81] . Low levels of tetracycline have been shown to increase transfer and the ability to spread antibiotic resistance genes to other isolates, species and genera [79] [80] [81] 87] . With their transfer ability, one might hypothesize that the ribosomal protection genes would be found in virtually all tetracycline-resistant genera examined, however this is not the case (Tables 1 and 2) .
A few isolates of Haemophilus spp. and two clones of high level tetracycline-resistant Moraxella catarrhalis carry the Tet B determinant in their chromosome [88, 89] . The Tet B determinant is not conjugative in these isolates, but can be moved by transformation using chromosomal DNA. More recently, we have found the Tet B determinant in Treponema denticola, an anaerobic spirochete thought to have an important role in periodontal disease ( [131] ). In the T. denticola isolates, the Tet B determinant was nonmobile and not associated with a plasmid suggesting that Tet B determinant was most likely located on the chromosome (author's unpublished observations). This is the first description of a Gram-negative effiux gene in a strictly anaerobic species. Sequencing a section of the T. denticola tetB gene we found 90% sequence identity with tetB gene from TnlO. However, determining whether the tetB gene confers tetracycline resistance in T. denticola has been difficult to assess because of the organisms growth requirements (author's unpublished observations).
The Tet E determinant differs from the Tet A, Tet B, Tet C and the Tet D determinants because it is associated with large plasmids which are neither mobile nor conjugative [90, 91] . This may explain its limited distribution and predominance in aquatic environments and its prevalence in polluted marine sediments [92] ( Table 1 ). The Tet E determinant has also recently been associated with the chromosome [93] . Jones et al. [28] found that a correlation existed between the plasmid incompatibility group and the particular tet genes the plasmid carried. They suggested that some of the tet genes may have become genetically linked to specific incompatibility and/or replication genes and thus the distribution of these genes could reflect the occurrence of particular incompatibility groups in particular genera or species. This hypothesis has not been thoroughly examined and this relationship was not shown in an earlier study by Mendez [25] . However, both Jones [28] and Mendez [25] found that no plasmid carried more than one type of tet gene.
Gram-negative bacteria
Currently, there have been 32 genera of Gramnegative bacteria described in the literature where the mechanism of tetracycline resistance has been determined ( Table 1) . Two other tet genes, including tetl, have been described. Other uncharacterized tet genes likely exist since studies have identified tetracycline-resistant isolates which do not carry any of the know tet genes [91, 94, 95] . These 'new tet genes', most likely code for either effiux or ribosomal protection proteins and will hopefully be identified and characterized.
Nineteen genera have been identified which carry only effiux genes ( [97] . The Tet B determinant is not mobile in the small number of Moraxella [89] and Treponema isolates examined but it would be interesting to determine whether either A. actinomycetemcomitans or Haemophilus spp. could transfer their Tet B determinants into either of these genera.
Of the eight genera which carry the Tet M determinant some have complete conjugative elements like V. parvula and F. nucleatum [6, 98] , which are mobile while another species, 14. ducreyi, has a complete conjugative element integrated into a conjugative plasmid [61] . Other species carry nonconjugative incomplete elements in their chromosome like Neisseria spp., most L. innocua, and G. uaginalis [98] or incomplete elements on conjugative plasmids like N. gonorrhoeae (Table 3) [98, 99] . In N. gonorrhoeae, the incomplete transposons are associated with 25.2 MDa conjugative plasmids [60, 99] . The 25.2 MDa conjugative plasmids have one of two different deletions of the Tet M transposon [99] . One plasmid has a deletion downstream of a HincII site a/~one of the strains tested could act as a donor [129] .
b All carry the conjugative 25.2 MDa Tet M plasmid with one of the two deletions [99] . c Nine of ten isolates carry incomplete nonmobile Tet M, the tenth carried a mobile Tet M determinant [87] . d M. hominis appears to carry a complete Tet M transposon by Southern hybridization [98] , but the Tet M determinants have not been moved from M. hominis but this was without pregrowth in tetracycline [127] . e Nonconjugative plasmid location [130] . f Some S. aureus have the Tet M in the chromosome but not all, most isolates tested could not act as a donor [117] . g U. urealyticum appears to carry complete Tet M transposons by Southern hybridization.
and is found in plasmids isolated from N. gonorrhoeae, Kingella denitrificans, and Eikenella corrodens [99] . The second plasmid type has a deletion of over 800 bp upstream of the HinclI site and is found in N. gonorrhoeae, N. meningitidis, and K. denitrificans .isolates [99] . Both types of plasmid confer resistance to > 16 /xg/ml tetracycline, which is high level resistance for these species. Both plasmid types transfer to other N. gonorrhoeae at frequencies ranging from 10 -1 to 10 -9 per recipient. Even though N. meningitidis has been found naturally with only one of the two plasmid types both are readily transferred by conjugation into N. meningitidis [99] . The 25.2 MDa plasmids can be stably transferred into a number of the commensal Neisseria spp. in the laboratory but to date only two species, N. perflava / sicca and N. mucosa, have been found that naturally carry the Tet M determinant [62, 98] . In all these isolates an incomplete Tet M transposon located in the chromosome has been found, rather than the 25.2 MDa plasmid (Table 3) . This illustrates that there are times that plasmids or genes can be moved in the laboratory which result in stable transconjugants but similar isolates are not found in nature. Both 25.2 MDa plasmids are able to be transferred, in the laboratory, into Haemophilus spp. and to K. denitrificans, E. corrodens, but not to Moraxella catarrhalis which carries nonmobile tetB rather than the tetM gene [61, 62, 100] . Once the Neisseria 25.2 MDa plasmid is in Haemophilus spp. they are easily transferred among species within the genus Haemophilus but not back to Neisseria spp. [61] . Similarly a H. ducreyi plasmid which carries the complete Tet M transposon can be transferred among Haemophilus spp. but one has not been successful in moving it outside the genus [61] . This type of plasmid incompatibility may influence the spread of particular tet genes into new genera.
The Tet Q determinant was first described in human colonic Bacteroides spp. and is normally associated with conjugative elements [77, 78] . This gene is now found in a number of Prevotella spp. from the oral cavity as well as in other Gram-negative oral genera such as Mitsuokella, Capnocytophaga, and Veillonella [101] . A total of six different Gram-negative genera currently have been shown to carry this gene (Table 1 ). In addition, the tetQ gene has been found in five Gram-positive genera (Table 2) ([ 102] , author's unpublished observations). The extent of the host range of the tetQ gene is just now being examined and it is possible that tetQ gene's host range might be similar to what has been found for the tetM gene.
The number of different tet genes found in a particular Gram-negative genus varies from one tet gene which is found in 14 genera carrying either tetB (efflux), terM or tetQ (both ribosomal protection), to a high of six different tet efflux genes found in Escherichia spp. and Vibrio spp. (Table 1 ). Tet G [103, 104] , Tet H [40] and Tet I [29] determinants have not been extensively examined for their distribution in Gram-negative bacteria and may be more widely distributed than indicated in Table 1 . It is clear that many environmental [92] , food [87] and animal isolates [65, 90, 91, 93, 103] are tetracycline-resistant, however these have not yet been as extensively examined as bacteria associated with human disease. There has been little work done to elucidate why some genera carry only a single tet gene, while members of other genera can carry a variety of different tet genes. The mobility of a particular gene certainly plays some role in gene distribution but to what extent is not clear. The environment a particular bacterium resides in may also play an important role in influencing what genes that bacterium carries, especially if the environment is polluted or exposed to antibiotics [1, 92] . More work needs to be done to better understand the factors which influence not only whether the bacteria will carry tetracycline resistance, but which and how many determinants will be found in a particular species or genus.
The majority of Gram-negative isolates described in the literature carries a single Tet determinant. This was evident from the earliest studies of the distribution of tet genes when it was found that 3.5% of the lactose-fermenting coliforms carried two different tet genes [105] . When bacteria from catfish and their environment were studied, the authors found that 2% of the 161 isolates examined carried both tetA and tetE genes, while 0.6% of the Plesiomonas shigelloides, 0.9% of the Aeromonas hydrophila, 2% of the Citrobacterfreundii, 11% of the E. coli carried two different efflux genes [106, 107] . In contrast, none of the E. tarda, K. pneumoniae or Enterobacter spp. carried more than a single tet gene. When Shigella spp. from Mexico were examined [108] , 12% of the 33 isolates carried either tetA and tetB or tetC and tetD genes, but the 16 Salmonella ~-phimurium carried only a single tet determinant. Another study showed, three of 97 (3%) African Salmonella typhimurium isolates examined carried both tetA and tetB genes [109] . In fact the only study where Gram-negative species were reported in high number to carry more than a single tet gene is the recent study of polluted marine sediments from Norway [92] . In that study, 26% of tetracycline-resistant isolates carried both Tet D and Tet E determinants.
The host ranges of Gram-negative plasmids have been studied and a number of incompatibility groups defined [25, 28] . Plasmid host ranges vary from very restrictive, such as found with the large conjugative Haemophilus R-plasmids [61, 110] which do not readily survive outside their own genus, to broad host ranges which allow the plasmid to survive in diverse host backgrounds [111] .
Gram-negative anaerobic species and some nonenteric Gram-negative species like Neisseria, Eikenella, Kingella most commonly or exclusively carry ribosomal protection genes (terM, tetO, tetQ). The one exception is the genus Haemophilus, especially H. influenzae and H. parainfluenzae where all of the isolates described in the literature have carried the tetB efflux gene [88] . However, no recent studies have been done to see if this is as true in 1996 as it was in the 1970's. A few isolates of Haemophilus aphrophilus, isolated from periodontal patients in the 1990's, have been found to carry the tetK gene [53] , while H. ducreyi has been found to carry either tetB or terM genes [88, 89] . A few isolates of V. parvula have been found which carry either tetL or tetQ, however most of the isolates examined carry the terM gene (author's unpublished observations). Most tetracycline-resistant Bacteroides spp. carry the tetQ gene (author's unpublished observations). However, a few isolates with the tetX [66] and one species of Bacteroides with the tetM gene has been described [95] . Recently, different tet genes have been found within the genus Pasteurella [40, 65] .
Eight Gram-negative genera have been shown to carry tetM genes, six carry tetQ and one genus each carried tetG, tetH, tetI, tetL, tetK, or tetO. Based on their low G + C content and their regulation (see Section 3) tetK, tetL, tetM, and tetO genes are believed to be of Gram-positive origin. Thus, the genera listed on the right hand column in Table 1 provide good examples of Gram-positive genes which have been spread in nature to Gram-negative species. This strengthens the hypothesis that antibiotic resistance genes from Gram-positive species have been exchanged throughout the bacterial population without regard to species or genus and can be successfully integrated and expressed in a variety of bacterial host backgrounds [21, 112, 113] .
Gram-positive bacteria
Twenty-two genera of Gram-positive bacteria and related species (Table 2) have been described where the mechanism of tetracycline resistance is known (Table 2) . However, not all tetracycline-resistant Gram-positive bacteria have been shown to carry known tet genes [64, 94] . Ten genera have been identified which carry only ribosomal protection genes. Of these, seven carry the tetM, while isolates of the remaining three genera carry two of the following genes: tetM, tetO, tetQ. The Nocardia spp. carry the tetK effiux gene and Bacillus spp. can carry one of two effiux genes (tetK, tetL). The remaining ten genera carry both effiux and ribosomal protection genes often in combination [27, 52, 64] .
Mobility and host range of the various Gram-positive tet genes and plasmids, as well as the environmental factors may influence the distribution of the tet genes through populations and into different genera including Gram-negative species. The tetK and tetL genes are widely distributed among Gram-positive species associated with man, animals and the soil (Tables 1 and 2 ) and have recently been found in rapidly growing Mycobacterium spp. and Streptomyces spp. [53, 114] and more recently Nocardia, all isolated from patients (author's unpublished results) ( Table 2 ). This is the first time that acquisition of an antibiotic-resistance determinant has been documented in Mycobacterium and suggests that gene exchange between tetracycline-resistant Gram-positive bacteria, Mycobacterium, Nocardia and Streptomyces has occurred. The hypothesis that Streptomyces spp. do exchange antibiotic resistance genes with other genera is strengthened by our recent discovery of the Otr determinants, from industrial Streptomyces, in clinical isolates of Mycobacterium spp. and Streptomyces spp. [114] . This is consistent with the hypothesis that some of the tet genes could be ancestrally related to genes found in the antibiotic-producing Streptomyces [35] . Work is still needed to determine the host range of the otr genes.
The Tet M determinant is often associated with a conjugative element of the Tn916-Tn1545 family [79] . This group of elements form nonreplicating circular intermediates which are essential both for intracellular transposition and intercellular conjugative transfer [79, 83] . Both types of movements are by an excision-integration process where excision and formation of a covalently closed circular molecule precedes movement of the conjugative element. In both Tn916 and Tn1545 imperfect inverted repeats (20 of 26 bp) are present at the ends of the transposon and integration occurs without duplication of the target DNA sequence [79, 83] . More recently Manganelli et al. [82] has shown that the number of circular intermediates varies in different E. faecalis strains. Their work indicates that the number of circular intermediates influences the frequency of conjugation between 5.1 X 10 -s and 2.8 X 10 -6, while Rice [85] demonstrated that the number of circular intermediates increased when the strains were grown in the presence of tetracycline.
Clewell [79] recently determined that the Tn916 family of elements was found naturally or could be transferred in the laboratory into over 50 different species representing 24 genera of bacteria. However, the host range of the Tn916 family is even greater than this as demonstrated by Tables 1 and 2 and references [65, 87, 98, 115, 116] . Currently, the Tet M determinant has been found naturally in 16 Grampositive and eight Gram-negative genera (Tables l  and 2 ). The Tet M determinant can also be introduced into a significant number of other genera including Gram-negative, Gram-positive and species lacking cell walls [6, 81, 87, 97, 112, 113] . In a majority of Gram-positive species, the Tet M determinant is found in the chromosome, most often on conjugative elements [79, 85, 86] . However, exceptions do exist and are listed in Table 3 , but this is not a complete list of what is found in nature because Horaud et al. [117] demonstrated that among a variety of streptococci only about 30% of the tetM genes carried were conjugative, suggesting that many of these genes were associated with nonmobile/incomplete Tet M transposons. Whether these elements are nonmobile because they are incomplete transposons or if it is due to where the transposon is located in the bacteria has not been evaluated. Little has been done with the Tet S determinant other than to show transfer between L. monocLvtogenes and E. faecalis at frequencies ranging from 10 -4 to 10 -9 [1 18 ]. The tetS gene can be associated with either conjugative plasmids or what appear to be conjugative transposons [26, 118] . The Tet O determinant is not associated with conjugative elements and is mobile only when found on conjugative plasmids [63, 94] . These can be transferred among streptococci and Campylobacter [63, 102] . The tetQ has been identified in Gram-positive species (Table 2) ; however, whether these are associated with conjugative elements is currently not known. Using the terM as a model, there is a high probability that the tetQ gene is associated with conjugative elements in both Gram-positive and Gram-negative bacteria [78] .
Gram-positive bacteria more commonly carry multiple tet genes than has been seen for Gramnegative bacteria [21, 52, 64] . In the recent study of tetS [118] , 22 E. faecalis were shown to carry tetS, nine (27%) also carried tetM and three (14%) carried both tetM and tetL. Similarly, when we looked at tetracycline-resistant Peptostreptococcus spp., viridans streptococci and Streptococcus agalactiae isolated from the urogenital tract, 36% of the hybridizing Peptostreptococcus spp., 64% of the hybridizing streptococci and 31% of the hybridizing S. agalactiae carried multiple tet genes [64] . Why the Grampositive isolates more often carry multiple tet genes is not clear since isolates carrying multiple tet genes cannot often be identified by their MIC. However, Gram-positive isolates often carry multiple rRNA methylase genes [21, 52] suggesting that this property is not unique to the Gram-positive tet genes.
Conclusions
Tetracyclines are used for both infectious and noninfectious diseases in man. There is also significant use of these antibiotics throughout the agriculture industry. Often the most significant use of antibiotics, in tonnage, is as a subtherapeutic growth promoter in animals [1] . The first tetracycline resistance R-factors were identified 40 years ago in Japan [17] [18] [19] . Since then, tetracycline resistance genes have spread in both Gram-negative and Gram-positive genera, primarily by conjugal transfer of plasmids and/or transposons. The literature has documented the dramatic increase in the number of species and genera which have acquired tetracycline resistance since the 1950's. This has in turn led to a reduction in the efficacy of current tetracycline therapy for many diseases. New tetracycline analogs are being examined which are resistant to both efflux and ribosomal protection mechanisms of tetracycline resistance [ 13, 120, 121 ] . However, these compounds are years away from clinical use. In addition, we have already found clinical multi-drug resistant Gram-negative isolates which are resistant to the new glycylcyclines compounds (author's unpublished observations). However, unlike the mutants created by Guay et al. [37] these are as resistant to tetracycline (> 125 p.g/ml) as other isolates carrying efflux tet genes as well as being resistant to the glycyclcylines (> 8 /zg/ml). This indicates that bacteria can become resistant to these analogs in nature without loss of tetracycline resistance. However, the mechanism of resistance to the glycylcyclines has not been determined, nor have we examined whether this phenotype can be transferred by conjugation.
The widespread distribution of specific tet genes like tetB or tetM supports the hypothesis that the tet genes are exchanged by bacteria from many different ecosystems. Thus, bacteria exposed to antibiotics in the environment or in animals can ultimately influence antibiotic resistance in bacteria of human origin. The presence of Gram-positive tet genes in natural Gram-negative species supports the hypothesis that Gram-positive genes are being introduced and maintained in Gram-negative species in nature. It is very likely that this trend will continue with more Gram-positive genes becoming stably maintained in Gram-negative hosts. Low-level exposure to tetracycline promotes production of the mRNA and protein for the Gram-negative efflux genes and production of the protein from the mRNA in the Gram-positive efflux genes and at least some of the ribosomal protection genes. Small amounts of tetracycline can also promote transfer of some of the tet genes (tetM and tetQ). In the presence of a subtherapeutic dose of tetracycline tet genes are more likely to spread to other bacteria. Long-term use of tetracycline has been shown to not only select for resistance to tetracycline but also for multi-drug resistance bacteria [ 1 ] . The use of tetracyclines for growth promotion in food production and for noninfectious diseases certainly contributes to the worldwide bacterial exposure to tetracycline.
The Gram-negative efflux systems have been extensively studied especially in TnlO. Tet A-E, Tet G, Tet H determinants and perhaps the Tet I determinant have a common genetic organization and show ancestral relationships both in the efflux and regulation proteins. Genetic relationships are found with the Gram-positive efflux proteins (TetK, TetL) and among the different ribosomal protection proteins (TetM, TetO, TetS). Both efflux and ribosomal protection proteins are found in antibiotic-producing streptomycetes [30] [31] [32] [33] .
The facultative Gram-negative efflux genes are primarily associated with classic transposons which are on a diverse group of plasmids [28] . The Tet B determinant has the widest host range, and is the only efflux gene which confers resistance to both tetracycline and minocycline. Escherichia spp. and Vibrio spp. host the largest number of different Tet determinants (Table 1) . Many of the Vibrio spp. are associated with fish diseases and/or water and have been subjected to extensive exposure to antibiotics because of fish aquaculture and their prevalence in the developing world [1, 17, [90] [91] [92] 103, 104] . E. coli are also found in this environment [91, 107] . Whether the environment can, or does, influence bacteria's ability to acquire different tet genes or other antibiotic resistance genes is unknown. However, it is likely that an environment where there are large numbers of bacteria with many different species represented can provide an excellent climate for gene exchange. Why various Gram-negative enteric genera. only carry some of the Gram-negative efflux genes is also not clear. We have speculated that the reduced host range of the tetE may be due to its association with nonmobile and nonconjugative plasmids [90, 91] . Perhaps there is a linkage between tet genes and particular incompatible plasmids as Jones and colleagues suggest [28] . It is also possible that the ribosomal protection genes have not yet been found in enteric species because they confer relatively low level tetracycline resistance in these hosts. However, given time and enough tetracycline exposure, this barrier may be breached in the future as have so many in the past [6] .
Gram-positive efflux genes (tetK and tetL) have recently been found in isolates of Haemophilus spp. and Veillonella spp., both of which can also carry the ribosomal protection tetM gene. Thus, the Grampositive efflux genes are starting to appear in natural Gram-negative isolates which gives the Gram-negative species more options for acquiring different tet genes. The ribosomal protection genes have the widest host range and are found in a number of Gram-positive and Gram-negative species suggesting that they may have an advantage when it comes to being distributed among the different genera.
The tet genes are found in bacterial pathogens, opportunistic and normal flora species. Significant numbers of normal flora bacteria from the urogenital, oral/respiratory, and the gastrointestinal tract of man and animals, as well as bacteria isolated from food and the environment, are resistant to tetracycline [1, 6, 25, 40, 51, 52, 87, [91] [92] [93] 116] . The normal human flora may act as a reservoir for antibiotic resistance genes in general and tet genes specifically [6, 64] . Similarly, the normal flora in animals and the bacteria in environment may also play important roles as reservoirs for antibiotic resistance genes including the tet genes [102] . Over the last 40 years we have seen pathogens become resistant to more and more antibiotics. To help reverse this trend we will need to reduce the antibiotic-resistant bacteria found in the normal flora of man and animals, in food and the environment. To do this will require changes in the way antibiotics are used in the health care of man, food production, therapy of animals and use for noninfectious diseases. Without change, the world will continue to drift toward the time when pathogens will be resistant to all available therapy and we will have entered the 'post-antimicrobial era' that Cohen [ 122] has predicted.
According to the Centers for Disease Control and Prevention, most antimicrobial use in humans is for treatment of outpatient infections where, in 1992, an estimated 110 million courses of antimicrobial therapy were prescribed ( [123] ). Trends in antimicrobial drug prescribing among office-based physicians in the United States ( [123] ) found that antimicrobial use in children below the age of 15 is more than three times greater than the rate of any other age group within the population. The leading diagnoses resulting in antimicrobial prescriptions were otitis media, upper respiratory infection, bronchitis, sinusitis and pharyngitis. Otitis media is the second leading cause of office visits, the leading cause of emergency visits and accounts for > 40% of all outpatient antimicrobial use in children [123, 124] . The Centers for Disease Control and Prevention are pushing to reduce antimicrobial prescription in conditions which may not warrant antibiotic therapy. They are now setting up studies to determine if education of the clinician and/or the parents can help to reduce the prescribing of antibiotics in this patient population.
Recently, the Report of the ASM Task Force on Antibiotic Resistance [125] listed a series of recommendations which they felt would be important in dealing with the problem of the ever-increasing an-tibiotic-resistant bacteria population. The list of recommendations includes: (1) national surveillance system to address the magnitude of the current problems related to antibiotic resistance; (2) professional (medical, dental, and veterinary) education on appropriate use of antibiotics; (3) public education of patients and food producers so they would understand what antibiotics can do to the ecosystem and how the cumulative effect of antibiotic use selects for progressively more resistant bacteria; (4) basic research in development of new antimicrobial compounds including totally novel compounds; (5) research into the mechanism of antibiotic resistance and how these resistance genes and organisms spread through populations; (6) research to identify the optimal therapeutic options for treatment of infection with antibiotic-resistant isolates; (7) better definition of when antibiotic therapy is and is not needed for otitis and respiratory infections in all age groups; and (8) effective vaccines and other measures which would prevent disease and thus reduce the need for antimicrobial therapy. It was suggested that guidelines need to be established and enforced to reduce the spread of infectious agents and antibiotic-resistant bacteria. It would be desirable to have a set of similar recommendations which could be used worldwide. Unfortunately, in many nations, antibiotics are not well regulated and can be obtained without prescription which makes controlling their use more difficult. However, in this age of rapid travel and commercial movement of fruit and vegetables from one country to another, it will not be adequate to reduce antibiotic usage in only some of the nations. Instead a global effort is needed to combat the problem of increasing numbers of antibiotic-resistant bacteria.
Over the past 40 years the majority of new antimicrobial compounds have come from the pharmaceutical industry [1] . To bring an antimicrobial compound to market is time-consuming and requires considerable money. In this competitive world this makes the development of new antibiotics less attractive to companies than in the past. To change this, governments need to provide financial incentives to the pharmaceutical companies to encourage antibiotic drug research and development. Only with a partnership between industry, governments, clinicians, researchers and the general public will there be the possibility of change which will help prevent the world from entering the 'post-antibiotic era' where most infectious diseases can no longer be successfully treated with antibiotics.
